QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.105.097501v1 316/3/1031    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hambrock, A. Articles by Osswald, H. Search for Related Content PubMed PubMed Citation Articles by Hambrock, A. Articles by Osswald, H.

CELLULAR AND MOLECULAR

Glibenclamide-Induced Apoptosis Is Specifically Enhanced by Expression of the Sulfonylurea Receptor Isoform SUR1 but Not by Expression of SUR2B or the Mutant SUR1(M1289T)

Department of Pharmacology and Toxicology, Medical Faculty, University of Tübingen, Tübingen, Germany

Sulfonylurea receptor 1 (SUR1) is the regulatory subunit of the pancreatic ATP-sensitive K⁺ channel (K_ATP channel), which is essential for triggering insulin secretion via membrane depolarization. Sulfonylureas, such as glibenclamide and tolbutamide, act as K_ATP channel blockers and are widely used in diabetes treatment. These antidiabetic substances are known to induce apoptosis in pancreatic -cells or -cell lines under certain conditions. However, the precise molecular mechanisms of this sulfonylurea-induced apoptosis are still unidentified. To investigate the role of SUR in apoptosis induction, we tested the effect of glibenclamide on recombinant human embryonic kidney 293 cells expressing either SUR1, the smooth muscular isoform SUR2B, or the mutant SUR1(M1289T) at which a single amino acid in transmembrane helix 17 (TM17) was exchanged by the corresponding amino acid of SUR2. By analyzing cell detachment, nuclear condensation, DNA fragmentation, and caspase-3-like activity, we observed a SUR1-specific enhancement of glibenclamide-induced apoptosis that was not seen in SUR2B, SUR1(M1289T), or control cells. Coexpression with the pore-forming Kir6.2 subunit did not significantly alter the apoptotic effect of glibenclamide on SUR1 cells. In conclusion, expression of SUR1, but not of SUR2B or SUR1(M1289T), renders cells more susceptible to glibenclamide-induced apoptosis. Therefore, SUR1 as a pancreatic protein could be involved in specific variation of -cell mass and might also contribute to the regulation of insulin secretion at this level. According to our results, TM17 is essentially involved in SUR1-mediated apoptosis. This effect does not require the presence of functional Kir6.2-containing K_ATP channels, which points to additional, so far unknown functions of SUR.

Address correspondence to: Dr. Annette Hambrock Department of Pharmacology and Toxicology, Medical Faculty, University of Tübingen, Wilhelmstrae 56, D-72074 Tübingen, Germany. E-mail: annette.hambrock{at}uni-tuebingen.de

This article has been cited by other articles:

				S. Ackermann, S. Hiller, H. Osswald, M. Losle, A. Grenz, and A. Hambrock 17{beta}-Estradiol Modulates Apoptosis in Pancreatic {beta}-Cells by Specific Involvement of the Sulfonylurea Receptor (SUR) Isoform SUR1 J. Biol. Chem., February 20, 2009; 284(8): 4905 - 4913. [Abstract] [Full Text] [PDF]

				N. Nakano, N. Miyazawa, T. Sakurai, T. Kizaki, K. Kimoto, K. Takahashi, H. Ishida, M. Takahashi, K. Suzuki, and H. Ohno Gliclazide Inhibits Proliferation but Stimulates Differentiation of White and Brown Adipocytes J. Biochem., November 1, 2007; 142(5): 639 - 645. [Abstract] [Full Text] [PDF]

				A. Hambrock, C. B. de Oliveira Franz, S. Hiller, A. Grenz, S. Ackermann, D. U. Schulze, G. Drews, and H. Osswald Resveratrol Binds to the Sulfonylurea Receptor (SUR) and Induces Apoptosis in a SUR Subtype-specific Manner J. Biol. Chem., February 2, 2007; 282(5): 3347 - 3356. [Abstract] [Full Text] [PDF]